Global Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Others), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centers, Hospitals and Clinics, Research Institutes, Cryobanks), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Data Bridge Market Research analyses that the infertility testing market to account USD 722.59 by 2028 and growing at a CAGR of 6.75% in the forecast period of 2021-2028.
Infertility testing is a series of tests which is used to determine why a woman is unable to conceive. The tests also aids in determining whether the issue is with the man, woman, or both. Infertility testing and evaluation are costly and the treatment might be a little uncomfortable at times. Sperm penetration assay, DNA fragmentation and oxidative stress analysis are examples of male infertility tests while laparoscopy, ovulation testing, hormone testing and ovarian reserve testing are examples of female infertility tests. Infertility testing is performed in the research institutes, hospitals, fertility centers and clinics.
Rising infertility and growing awareness about its treatment are the major factors that will influence the growth of the infertility testing market. Furthermore, medical tourism for fertility treatments, rise in the rate of disorders related with gynaecology and rising effectiveness of treatments are the driving factor accelerating the growth of the infertility testing market.
Increasing focus on research and development activities and technological advancements will further provide beneficial opportunities for the market growth.
However, the high cost of treatment and testing and the accuracy issues of testing kits will obstruct the market growth. The regulation issues prevailing in the countries will challenge the infertility testing market.
This infertility testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infertility testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Infertility Testing Market Scope and Market Size
The infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The infertility testing market is segmented on the basis of type into female infertility testing and male infertility testing. Female infertility testing has been further sub-segmented into ovulation testing, hysterosalpingography, laparoscopy, transvaginal ultrasound, ovarian reserve testing, hormone testing and others. Male infertility testing has been further sub-segmented into DNA fragmentation, oxidative stress analysis, sperm penetration assay, computer aided semen analysis, sperm agglutination assay, microscopic examination and others.
- On the basis of test kits, the infertility testing market is segmented into follicular stimulating hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits, and others.
- On the basis of prescription mode, the infertility testing market is segmented into prescription based and over the counter (OTC) based.
- On the basis of distribution channel, the infertility testing market is segmented into hospitals pharmacies, online pharmacies, pharmacies & drug stores.
- On the basis of end-user, the infertility testing market is segmented into fertility centers, hospitals and clinics, research institutes, and cryobanks.
Infertility Testing Market Country Level Analysis
The infertility testing market is analysed and market size insights and trends are provided by country, type, test kits, prescription mode, distribution channel and end-user as referenced above.
The countries covered in the infertility testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infertility testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to presence of major key players, well-developed healthcare infrastructure and high disposable income in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the infertility testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The infertility testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infertility testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Infertility Testing Market Share Analysis
The infertility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infertility testing market.
The major players covered in the infertility testing market report are Metropolis Healthcare Limited India, CENTOGENE N.V, Halotech DNA, Procter & Gamble, Andrology Solutions, SA Scientific, bioMérieux SA, Abbott, Quidel Corporation, Atlas Medical Uk, Babystart, SCSA Diagnostics, Gem, Merck KGaA, bioZhena Corporation, Vitrolife, Progyny Inc., Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Thermo Fisher Scientific, Siemens, Stryker, Mayo Foundation for Medical Education and Research (MFMER) and Dr Lal PathLabs, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Infertility Testing Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.